Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23) 23
Conference Proceeding (2) 2
Publication (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
oncology (8) 8
alk (5) 5
crizotinib (5) 5
humans (5) 5
respiratory system (5) 5
female (4) 4
resistance (4) 4
ros1 (4) 4
acquired resistance (3) 3
alectinib (3) 3
biomechanics (3) 3
brigatinib (3) 3
chemotherapy (3) 3
engineering, biomedical (3) 3
knee (3) 3
male (3) 3
middle aged (3) 3
mutation (3) 3
nsclc (3) 3
open-label (3) 3
walking (3) 3
aged (2) 2
arthroplasty (2) 2
article (2) 2
biophysics (2) 2
blindleistung (2) 2
ceritinib (2) 2
compensatory strategy (2) 2
drug-combinations (2) 2
eml4-alk (2) 2
kinematics (2) 2
knee joint - physiology (2) 2
kras (2) 2
lung neoplasms - genetics (2) 2
non-small cell lung cancer (2) 2
non–small cell lung cancer (2) 2
physiological aspects (2) 2
rotary instability (2) 2
rotation (2) 2
total knee replacement (2) 2
acquired-resistance (1) 1
adenocarcinoma (1) 1
adenocarcinomas (1) 1
adult (1) 1
advertising (1) 1
aged, 80 and over (1) 1
analysis, appreciation (1) 1
analytical guides (1) 1
anaplastic lymphoma kinase (1) 1
anaplastic lymphoma kinase - genetics (1) 1
anatomy (1) 1
and nsclc (1) 1
animals (1) 1
anterior cruciate ligament (1) 1
análise, apreciação (1) 1
appreciation (1) 1
appreciation of music (1) 1
arthroplastik (1) 1
arthroplasty, replacement, knee (1) 1
ascent (1) 1
aspectos sociais (1) 1
asymmetry (1) 1
banking industry (1) 1
bewegungsbereich (1) 1
bh3 mimetic abt-737 (1) 1
bim (1) 1
biochemical research methods (1) 1
biographies (1) 1
biomedical engineering (1) 1
biomedical materials (1) 1
body weight (1) 1
cadaver (1) 1
cancers (1) 1
capillary-electrophoresis (1) 1
capture (1) 1
carboxylic acids (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
cases (1) 1
cash management (1) 1
cell line, tumor (1) 1
cell lung-cancer (1) 1
cell separation (1) 1
cell-free dna (1) 1
check float (1) 1
chemiluminescence detection (1) 1
chemistry, analytical (1) 1
chirurgie (1) 1
class i phosphatidylinositol 3-kinases - genetics (1) 1
clinicopathological analysis (1) 1
clinicopathological features (1) 1
comparative analysis (1) 1
computer-modell (1) 1
concurrent mutations (1) 1
contact (1) 1
crizotinib - administration & dosage (1) 1
crizotinib - pharmacology (1) 1
cytometry (1) 1
dabrafenib plus trametinib (1) 1
descent (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Long-term efficacy and outcomes with sequential crizotinib followed by alectinib in ALK+ NSCLC
by Lin, Jessica Jiyeong and Yeap, Beow Y and Ferris, Lorin A and Yoda, Satoshi and Dagogo-Jack, Ibiayi and Lennerz, Jochen K and Gainor, Justin F and Shaw, Alice Tsang
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9093 - 9093
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text THE EFFECT OF GEOMETRY ON PATELLAR TRACKING AFTER TKA DURING SQUAT
by Shalhoub, Sami and Ferris, Lauren and Maletsky, Lorin
Journal of Biomechanics, ISSN 0021-9290, 2012, Volume 45, pp. S337 - S337
Physical Medicine and Rehabilitation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Analysis of a rotary task following total knee arthroplasty: Stair descent with a cross-over turn
by Linda M Denney and Lauren A Ferris and Hongying Dai and Lorin P Maletsky
Proceedings of the Institution of Mechanical Engineers, ISSN 0954-4119, 05/2014, Volume 228, Issue 5, p. 429
  Leg loading and knee angle differences have been reported in total knee replacement individuals during straight gait; however, little is known about the... 
Knee | Walking | Risk assessment | Comparative analysis | Joint replacement surgery
Journal Article
Details down arrow
4. Analysis of a rotary task following total knee arthroplasty: Stair descent with a cross-over turn
by Denney, Linda M and Ferris, Lauren A and Dai, Hongying and Maletsky, Lorin P
Proceedings of the Institution of Mechanical Engineers. Part H: Journal of Engineering in Medicine, ISSN 0954-4119, 05/2014, Volume 228, Issue 5, pp. 429 - 429
Leg loading and knee angle differences have been reported in total knee replacement individuals during straight gait; however, little is known about the impact... 
Surgical implants | Biomedical materials | Knees | Gait | Grounds | Strategy | Descent | Contact
Journal Article
Details down arrow
5. Full Text ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer
by Lin, Jessica J and Ritterhouse, Lauren L and Ali, Siraj M and Bailey, Mark and Schrock, Alexa B and Gainor, Justin F and Ferris, Lorin A and Mino-Kenudson, Mari and Miller, Vincent A and Iafrate, Anthony J and Lennerz, Jochen K and Shaw, Alice T
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2017, Volume 12, Issue 5, pp. 872 - 877
Chromosomal rearrangements involving the gene define a distinct molecular subset of NSCLCs with sensitivity to ROS1 inhibitors. Recent reports have suggested a... 
Non–small cell lung cancer | NSCLC | ROS1 | Concurrent mutations | ADENOCARCINOMA | REARRANGEMENTS | EGFR | IMPACT | ONCOLOGY | RESPIRATORY SYSTEM | Non-small cell lung cancer | CRIZOTINIB | KRAS | MUTATIONS | CLINICOPATHOLOGICAL ANALYSIS | Lung Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins c-akt - genetics | MAP Kinase Kinase 1 - genetics | Young Adult | Genes, erbB-1 | Protein-Tyrosine Kinases - genetics | Receptor Protein-Tyrosine Kinases - genetics | Genes, erbB-2 | Oncogene Fusion | Proto-Oncogene Proteins B-raf - genetics | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Mutation | non-small cell lung cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Sequential ALK inhibitors can select for lorlatinib-resistant compound ALK mutations in ALK-positive lung cancer
by Yoda, Satoshi and Lin, Jessica J and Lawrence, Michael S and Burke, Benjamin J and Friboulet, Luc and Langenbucher, Adam and Dardaei, Leila and Prutisto-Chang, Kylie and Dagogo-Jack, Ibiayi and Timofeevski, Sergei and Hubbeling, Harper and Gainor, Justin F and Ferris, Lorin A and Riley, Amanda K and Kattermann, Krystina E and Timonina, Daria and Heist, Rebecca S and Iafrate, A. John and Benes, Cyril H and Lennerz, Jochen K and Kenudson, Mari Mino and Engelman, Jeffrey A and Johnson, Ted W and Hata, Aaron N and Shaw, Alice T
Cancer Discovery, ISSN 2159-8274, 06/2018, Volume 8, Issue 6, pp. 714 - 729
The cornerstone of treatment for advanced ALK-positive lung cancer is sequential therapy with increasingly potent and selective ALK inhibitors. The... 
EML4-ALK | DRUG-COMBINATIONS | GENE | ONCOLOGY | CERITINIB | OVERCOMES CRIZOTINIB RESISTANCE | ALECTINIB | ACQUIRED-RESISTANCE | OPEN-LABEL | ROS1 | CHEMOTHERAPY | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Lung Neoplasms - chemically induced | Humans | Ethylnitrosourea - adverse effects | Drug Resistance, Neoplasm | Lactams, Macrocyclic - pharmacology | Anaplastic Lymphoma Kinase - genetics | Whole Exome Sequencing | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Oncogene Proteins, Fusion - genetics | Crizotinib - pharmacology | Cell Line, Tumor | Crizotinib - administration & dosage | Female | Lactams, Macrocyclic - administration & dosage | Mice | Protein Kinase Inhibitors - pharmacology | Mutation | Index Medicus | ALK | brigatinib | crizotinib | lorlatinib | and NSCLC | Anaplastic lymphoma kinase | ceritinib | acquired resistance | alectinib
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Impact of BRAF mutation class on disease characteristics and clinical outcomes in BRAF-mutant lung cancer
by Dagogo-Jack, Ibiayi and Martinez, Pablo and Yeap, Beow Y and Ambrogio, Chiara and Ferris, Lorin A and Lydon, Christine and Nguyen, Tom and Jessop, Nicholas A and John Iafrate, A and Johnson, Bruce E and Lennerz, Jochen K and Shaw, Alice T and Awad, Mark M
Clinical Cancer Research, ISSN 1078-0432, 01/2019, Volume 25, Issue 1, pp. 158 - 165
Purpose: BRAF mutations are divided into functional classes distinguished by signaling mechanism and kinase activity: V600-mutant kinase-activating monomers... 
DABRAFENIB PLUS TRAMETINIB | INHIBITION | ONCOLOGY | ADENOCARCINOMAS | SENSITIVITY | UNCOMMON | OPEN-LABEL | KRAS | CLINICOPATHOLOGICAL FEATURES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
by Dagogo-Jack, Ibiayi and Rooney, Marguerite and Nagy, Rebecca J and Lin, Jessica J and Chin, Emily and Ferris, Lorin A and Ackil, Jennifer and Lennerz, Jochen K and Lanman, Richard B and Gainor, Justin F and Shaw, Alice T
Journal of Thoracic Oncology, ISSN 1556-0864, 2019, Volume 14, Issue 5, pp. 816 - 824
Introduction: Circulating tumor DNA analysis is an emerging genotyping strategy that can identify tumor-specific genetic alterations in plasma including... 
Liquid biopsy | Targeted therapy | ROS1 | Lung cancer | VALIDATION | HETEROGENEITY | ONCOLOGY | RESPIRATORY SYSTEM | MUTATION | RESISTANCE | FUSIONS | CAPTURE | CELL-FREE DNA
Journal Article
Details down arrow
9. Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non–Small Cell Lung Cancer
by Lin, Jessica J and Chin, Emily and Yeap, Beow Y and Ferris, Lorin A and Kamesan, Vashine and Lennes, Inga T and Sequist, Lecia V and Heist, Rebecca S and Mino-Kenudson, Mari and Gainor, Justin F and Shaw, Alice T
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2019, Volume 14, Issue 1, pp. 135 - 140
Introduction: Immune checkpoint inhibitors (ICIs) are standard therapies in advanced NSCLC. Although genotype-directed tyrosine kinase inhibitors represent the... 
Crizotinib | Non–small cell lung cancer | Immune checkpoint inhibitor | Tyrosine kinase inhibitor | Hepatotoxicity | Immunotherapy | ONCOLOGY | SAFETY | RESPIRATORY SYSTEM | Non-small cell lung cancer | CHEMOTHERAPY | Index Medicus
Journal Article
Details down arrow
10. Full Text Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study
by Lin, Jessica J and Zhu, Viola W and Schoenfeld, Adam J and Yeap, Beow Y and Saxena, Ashish and Ferris, Lorin A and Dagogo-Jack, Ibiayi and Farago, Anna F and Taber, Angela and Traynor, Anne and Menon, Smitha and Gainor, Justin F and Lennerz, Jochen K and Plodkowski, Andrew J and Digumarthy, Subba R and Ou, Sai-Hong Ignatius and Shaw, Alice T and Riely, Gregory J
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. 1530 - 1538
ALK | brigatinib | NSCLC | resistance | alectinib
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
by Lin, Jessica J and Zhu, Viola W and Schoenfeld, Adam J and Yeap, Beow Y and Saxena, Ashish and Ferris, Lorin A and Dagogo-Jack, Ibiayi and Farago, Anna F and Taber, Angela and Traynor, Anne and Menon, Smitha and Gainor, Justin F and Lennerz, Jochen K and Plodkowski, Andrew J and Digumarthy, Subba R and Ou, Sai-Hong Ignatius and Shaw, Alice T and Riely, Gregory J
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. 1530 - 1538
The second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib recently showed superior efficacy compared to the first-generation ALK inhibitor... 
Brigatinib | ALK | Resistance | Alectinib | NSCLC | OPEN-LABEL | PHASE-3 | SINGLE-ARM | CHEMOTHERAPY | CELL LUNG-CANCER | TRIAL | EML4-ALK | ONCOLOGY | CERITINIB | RESPIRATORY SYSTEM | CRIZOTINIB
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Exploiting MCL-1 dependency with combination MEK + MCL-1 inhibitors leads to induction of apoptosis and tumor regression in KRAS mutant non-small cell lung cancer
by Nangia, Varuna and Siddiqui, Faria M and Caenepeel, Sean and Timonina, Daria and Bilton, Samantha J and Phan, Nicole and Gomez-Caraballo, Maria and Archibald, Hannah L and Li, Chendi and Fraser, Cameron and Rigas, Diamanda and Vajda, Kristof and Ferris, Lorin A and Lanuti, Michael and Wright, Cameron D and Raskin, Kevin A and Cahill, Daniel P and Shin, John H and Keyes, Colleen and Sequist, Lecia V and Piotrowska, Zofia and Farago, Anna F and Azzoli, Christopher G and Gainor, Justin F and Sarosiek, Kristopher A and Brown, Sean P and Coxon, Angela and Benes, Cyril H and Hughes, Paul E and Hata, Aaron N
Cancer discovery, ISSN 2159-8274, 12/2018, Volume 8, Issue 12, pp. 1598 - 1613
BH3 mimetic drugs, which inhibit pro-survival BCL-2 family proteins, have limited single-agent activity in solid tumor models. The potential of BH3 mimetics... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Exploiting MCL1 dependency with combination MEK + MCL1 inhibitors leads to induction of apoptosis and tumor regression in KRAS-Mutant non–small cell lung cancer
by Nangia, Varuna and Siddiqui, Faria M and Caenepeel, Sean and Timonina, Daria and Bilton, Samantha J and Phan, Nicole and Gomez-Caraballo, Maria and Archibald, Hannah L and Li, Chendi and Fraser, Cameron and Rigas, Diamanda and Vajda, Kristof and Ferris, Lorin A and Lanuti, Michael and Wright, Cameron D and Raskin, Kevin A and Cahill, Daniel P and Shin, John H and Keyes, Colleen and Sequist, Lecia V and Piotrowska, Zofia and Farago, Anna F and Azzoli, Christopher G and Gainor, Justin F and Sarosiek, Kristopher A and Brown, Sean P and Coxon, Angela and Benes, Cyril H and Hughes, Paul E and Hata, Aaron N
Cancer Discovery, ISSN 2159-8274, 12/2018, Volume 8, Issue 12, pp. 1598 - 1613
BH3 mimetic drugs, which inhibit prosurvival BCL2 family proteins, have limited single-agent activity in solid tumor models. The potential of BH3 mimetics for... 
DRUG-COMBINATIONS | MEK INHIBITION | ONCOLOGY | BIM | RESISTANCE | REGULATORS | BH3 MIMETIC ABT-737 | PROTEINS | EXPRESSION | DOCETAXEL | TRAMETINIB GSK1120212
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Molecular Analysis of Plasma from Patients with ROS1-Positive Non-Small Cell Lung Cancer
by Dagogo-Jack, Ibiayi and Rooney, Marguerite and Nagy, Rebecca J and Lin, Jessica J and Chin, Emily and Ferris, Lorin A and Ackil, Jennifer and Lennerz, Jochen K and Lanman, Richard B and Gainor, Justin F and Shaw, Alice T
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 01/2019
Circulating tumor DNA analysis is an emerging genotyping strategy that can identify tumor-specific genetic alterations in plasma including mutations and... 
Journal Article
Details down arrow
15. Lorin, Philippe. 5 giants of advertising. (New York, NY: Assouline Publishing Inc.)
by Ferris, Byron
12/2001, Volume 43, Issue 7
The five advertising giants profiled are David Ogilvy, Leo Burnett, Bill Bernbach, Albert Lasker and Marcel Bleustein-Blancher. 
Book Chapter
Details down arrow
16. Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors through Longitudinal Analysis of Circulating Tumor DNA
by Dagogo-Jack, Ibiayi and Brannon, A Rose and Ferris, Lorin A and Campbell, Catarina D and Lin, Jessica J and Schultz, Katherine R and Ackil, Jennifer and Stevens, Sara and Dardaei, Leila and Yoda, Satoshi and Hubbeling, Harper and Digumarthy, Subba R and Riester, Markus and Hata, Aaron N and Sequist, Lecia V and Lennes, Inga T and Iafrate, A John and Heist, Rebecca S and Azzoli, Christopher G and Farago, Anna F and Engelman, Jeffrey A and Lennerz, Jochen K and Benes, Cyril H and Leary, Rebecca J and Shaw, Alice T and Gainor, Justin F
JCO precision oncology, ISSN 2473-4284, 2018, Volume 2018
rearrangements predict for sensitivity to ALK tyrosine kinase inhibitors (TKIs). However, responses to ALK TKIs are generally short-lived. Serial molecular... 
Journal Article
Details down arrow
17. Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1 -Positive Non-Small-Cell Lung Cancer
by Gainor, Justin F and Tseng, Diane and Yoda, Satoshi and Dagogo-Jack, Ibiayi and Friboulet, Luc and Lin, Jessica J and Hubbeling, Harper G and Dardaei, Leila and Farago, Anna F and Schultz, Katherine R and Ferris, Lorin A and Piotrowska, Zofia and Hardwick, James and Huang, Donghui and Mino-Kenudson, Mari and Iafrate, A John and Hata, Aaron N and Yeap, Beow Y and Shaw, Alice T
JCO precision oncology, ISSN 2473-4284, 2017, Volume 2017
The ROS1 tyrosine kinase is activated through gene rearrangements in 1-2% of non-small cell lung cancer (NSCLC), conferring sensitivity to treatment with the... 
Journal Article
Details down arrow
18. Full Text High-throughput microfluidic device for single cell analysis using multiple integrated soft lithographic pumps
: Miniaturization
by Patabadige, Damith E. W and Mickleburgh, Tom and Ferris, Lorin and Brummer, Gage and Culbertson, Anne H and Culbertson, Christopher T
ELECTROPHORESIS, ISSN 0173-0835, 05/2016, Volume 37, Issue 10, pp. 1337 - 1344
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Strategies utilized to transfer weight during knee flexion and extension with rotation for individuals with a total knee replacement
by Ferris, Lauren A and Denney, Linda M and Maletsky, Lorin P
Journal of Biomechanical Engineering, ISSN 0148-0731, 2013, Volume 135, Issue 2, pp. 021020 - 7
Functional activities in daily life can require squatting and shifting body weight during transverse plane rotations. Stability of the knee can be challenging... 
rotary instability | total knee replacement | compensatory strategy | weight transfer | WALKING | INSTABILITY | MOBILITY | ENGINEERING, BIOMEDICAL | ARTHROPLASTY | GAIT ANALYSIS | ASYMMETRY | BIOPHYSICS | MOVEMENT PATTERNS | IN-VIVO | OUTCOMES | KINEMATICS | Knee Joint - surgery | Body Weight | Knee Joint - physiology | Movement | Humans | Middle Aged | Arthroplasty, Replacement, Knee | Female | Male | Weight-Bearing | Aged | Rotation | Knee | Biomechanics | Physiological aspects | Research | Health aspects | Body weight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC
by Dagogo-Jack, Ibiayi and Stevens, Sara E and Lin, Jessica J and Nagy, Rebecca and Ferris, Lorin and Shaw, Alice T and Gainor, Justin F
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2018, Volume 13, Issue 11, pp. e226 - e227
CANCERS | ONCOLOGY | RESPIRATORY SYSTEM
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.